Asmora(@asmora_mcp):Really appreciate the recognition, @imaurer. Thanks for taking the time to acknowledge our work! Check out BioMCP if you have yet to.

2026.06.28 18:11

Really appreciate the recognition, @imaurer. Thanks for taking the time to acknowledge our work! Check out BioMCP if you have yet to.

Asmora@asmora_mcp

2026.06.27 19:35

BioMCP by @imaurer now enables biomedical agents to rapidly explore the treatment landscape for KRAS G12C-positive NSCLC using just seven CLI commands. By integrating data from 10+ biomedical sources, it retrieves therapeutic evidence, maps approved and investigational drugs, reviews FDA safety data, analyzes real-world adverse events, identifies recruiting clinical trials, and summarizes the latest resistance research all within a reproducible, end-to-end command-line workflow. Explore BioMCP on Asmora today: